Catalyst News and Research

RSS

Researchers open a kind of window into inner workings of lithium-ion battery

For the first time, researchers have been able to open a kind of window into the inner workings of a lithium-ion battery.

9 Sep 2014

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes.

4 Sep 2014

New approach to turn diseased cells into unique manufacturing sites for treating muscular dystrophy

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing sites for molecules that can treat a form of muscular dystrophy.

3 Sep 2014

World Economic Forum selects Health Catalyst as one of 24 global Technology Pioneers

Celebrating the power of technology and innovation, the World Economic Forum announced today it has selected Health Catalyst as one of 24 global Technology Pioneers. The award recognizes transformative companies at the forefront of their industries including previous Technology Pioneers: AirBnb, Cyberdyne, Azuri Technologies, Dropbox, Kickstarter, Solazyme, Twitter, Mozilla Corporation and Google.

26 Aug 2014

Study shows impact of nutrition rating systems on supermarket food sales

Can nutrition rating systems be used in supermarkets to encourage healthier spending habits? A new study by Cornell University researchers sought to answer that very question by tracking the purchasing records in a supermarket chain that uses the Guiding Stars System to rate the nutritional value of foods for sale.

20 Aug 2014

Researchers shed light on the dual action of aspirin

Hugely popular non-steroidal anti-inflammation drugs like aspirin, naproxen (marketed as Aleve) and ibuprofen (Advil, Motrin) all work by inhibiting or killing an enzyme called cyclooxygenase - a key catalyst in production of hormone-like lipid compounds called prostaglandins that are linked to a variety of ailments, from headaches and arthritis to menstrual cramps and wound sepsis.

19 Aug 2014

Cardiva Medical closes private equity financing and senior secured facility with GE Capital

Cardiva Medical, Inc. announced today that it has closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital.

19 Aug 2014

University of California launches 14 commercial startups in a year

The University of California, Davis, launched 14 commercial startups during the past year to June 30 - the largest number of new ventures based on UC Davis technology to be started in a single year.

14 Aug 2014

IUPUI receives $600,000 award from National Science Foundation for drug discoveries

Haibo Ge, Ph.D., assistant professor in the Department of Chemistry and Chemical Biology in the School of Science at Indiana University-Purdue University Indianapolis (IUPUI), is the recipient of a 5-year, $600,000 award from the National Science Foundation (NSF) to fund research that may one day contribute to drug discoveries.

14 Aug 2014

New program creates gap between cutting-edge academic research and market uptake

Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.

14 Aug 2014

Researchers reprogram nonribosomal peptide synthetases for clickable amino acids

A single targeted mutation is enough to alter a natural peptide system so that it also incorporates non-natural amino acids into peptides, report Swiss scientists in the journal Angewandte Chemie.

13 Aug 2014

Dynatronics completes $3.8M sale and leaseback of its Utah facility

Dynatronics Corporation (NASDAQ: DYNT) today announced the completion of a $3.8 million sale and leaseback of its facility in Cottonwood Heights, UT. The purchaser was AIC Ventures of Austin, Texas.

11 Aug 2014

IDEXX revenues increase 11% to $390M in second quarter 2014

IDEXX Laboratories, Inc. today reported that revenues for the second quarter of 2014 increased 11% versus the prior year period to $390 million.

25 Jul 2014

UT Arlington professor receives Community Development Society's Current Research Award for 2014

A University of Texas at Arlington professor who co-authored a book about the challenges faced by private foundations engaged in community revitalization has been awarded the Community Development Society's Current Research Award for 2014.

25 Jul 2014

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Gaston Picchio outlines the major findings of the recent report published by The Economist Intelligence Unit (EIU): ‘Tackling hepatitis C: Moving towards an integrated policy approach’

23 Jul 2014

Zilico receives funding to develop diagnostic device for oral cancer

Zilico Ltd has begun development work on a medical device which uses Electrical Impedance Spectroscopy (EIS) in the detection and diagnosis of oral cancer following funding from the Technology Strategy Board, the UK’s innovation agency.

From Zilico 23 Jul 2014

Baxter International acquires drug candidate developed to treat sickle cell disease

A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.

11 Jul 2014

Study identifies effective market research approaches to understand payer needs, decision-making

The Affordable Care Act has been the catalyst for dramatic change in US healthcare. The power structures that influence this $2.8 trillion economic sector are shifting, but one thing is crystal clear: A large percentage of the pharmaceutical sector's top-line revenues flow from payers.

28 Jun 2014

Researchers discover way to use water as solvent to synthesize chemical products

Green-chemistry researchers at McGill University have discovered a way to use water as a solvent in one of the reactions most widely used to synthesize chemical products and pharmaceuticals.

26 Jun 2014

USDM, DocuSign partner to help life science companies manage regulated business process

DocuSign, Inc. (DocuSign®) and USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, today announced a new partnership to help organizations automate regulated business processes for dramatic ROI, increased security and compliance, and faster speed to market.

23 Jun 2014

Catalyst News and Research

Researchers open a kind of window into inner workings of lithium-ion battery

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

New approach to turn diseased cells into unique manufacturing sites for treating muscular dystrophy

World Economic Forum selects Health Catalyst as one of 24 global Technology Pioneers

Study shows impact of nutrition rating systems on supermarket food sales

Researchers shed light on the dual action of aspirin

Cardiva Medical closes private equity financing and senior secured facility with GE Capital

University of California launches 14 commercial startups in a year

IUPUI receives $600,000 award from National Science Foundation for drug discoveries

New program creates gap between cutting-edge academic research and market uptake

Researchers reprogram nonribosomal peptide synthetases for clickable amino acids

Dynatronics completes $3.8M sale and leaseback of its Utah facility

IDEXX revenues increase 11% to $390M in second quarter 2014

UT Arlington professor receives Community Development Society's Current Research Award for 2014

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Zilico receives funding to develop diagnostic device for oral cancer

Baxter International acquires drug candidate developed to treat sickle cell disease

Study identifies effective market research approaches to understand payer needs, decision-making

Researchers discover way to use water as solvent to synthesize chemical products

USDM, DocuSign partner to help life science companies manage regulated business process

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News